…study NTLA-2002 in hereditary angioedema (HAE). There have been several other announcements related to clinical trials in the last few days, including positive data from trials in severe influenza and…

…study NTLA-2002 in hereditary angioedema (HAE). There have been several other announcements related to clinical trials in the last few days, including positive data from trials in severe influenza and…

GenSight Biologics has revealed pooled safety data from five clinical studies of lenadogene nolparvovec (Lumevoq), the largest cohort of ND4-LHON (Leber hereditary optic neuropathy) patients studied after gene therapy treatment….

…Trop2. Topline data from Phase II monotherapy module Redx has shared topline monotherapy data from the biliary tract cancer (BTC) module of the RXC004 PORCUPINE2 Phase II clinical trial programme….

…services that are open to the public are: a free data visualisation tool, curated metadata for 3860 MPLCN Assays, open source computational tools published on Github, and data contributed by…

Redx, a clinical-stage biotechnology company focused on discovering and developing novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic disease, has shared topline monotherapy data from…

…Merck, Amgen and Pfizer as well as American Red Cross and Quest Diagnostics; her expertise spans digital strategy, data analytics, cyber and data security, organisational transformation, and talent development. “I…

Poolbeg Pharma, an infectious disease-focused biopharmaceutical company, has announced data from the bacterial lipopolysaccharide (‘LPS’) human challenge trial for POLB 001, a viral strain agnostic, small molecule immunomodulator being developed…

…using the RNA expression pattern of their tumour and machine learning. Alba Health is on a mission to reduce chronic disease risks from childhood, leveraging data science and the latest…

…around the world through partnership with patient groups and the clinicians and healthcare institutions they attend. Establishing novel trial designs and methods (including effective, trustworthy use of data and technology)…